FAM3A is a target gene of peroxisome proliferator-activated receptor gamma

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 8, 2013, Pages 4160-4170

  Zhou, Yanlan ^a   Jia, Shi ^a   Wang, Chunjiong ^a   Chen, Zhenzhen ^a   Chi, Yujing ^a,b   Li, Jing ^a,b   Xu, Guoheng ^a,c,d   Guan, Youfei ^a,c,d   Yang, Jichun ^a,c,d  

^a Department of Physiology and Pathophysiology ^*  (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Akt; FAM3A; Nuclear receptor; PPAR ; PPRE

Indexed keywords

[4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; CYTOKINE; FAMILY WITH SEQUENCE SIMILARITY 3A PROTEIN; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FAM3A GENE; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOCATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; MALE; MOUSE; NONHUMAN; PEROXISOME PROLIFERATOR RESPONSE ELEMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CYTOKINES; HEP G2 CELLS; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PALMITATES; PPAR GAMMA; PROMOTER REGIONS, GENETIC; THIAZOLIDINEDIONES;

EID: 84877821856     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.03.029     Document Type: Article

References (51)

1. R.M. Evans 2003 Keio Medical Science Prize commemorative lecture. PPARs and the complex journey to obesity Keio. J. Med. 53 2004 53 58
2. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat. Med. 10 2004 355 361 (Pubitemid 38508511)
3. J. Yang, D. Zhang, J. Li, X. Zhang, F. Fan, and Y. Guan Role of PPARgamma in renoprotection in type 2 diabetes: molecular mechanisms and therapeutic potential Clin. Sci. (Lond.) 116 2009 17 26
4. B.S. Muhlhausler, J.L. Morrison, and I.C. McMillen Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation Endocrinology 150 2009 4287 4294
5. F. Aguilo, N. Camarero, J. Relat, P.F. Marrero, and D. Haro Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma Biochem. J. 427 2010 255 264
6. C.F. Zizola, G.J. Schwartz, and S. Vogel Cellular retinol-binding protein type III is a PPARgamma target gene and plays a role in lipid metabolism Am. J. Physiol. Endocrinol. Metab. 295 2008 E1358 E1368
7. K. Matsusue, T. Kusakabe, T. Noguchi, S. Takiguchi, T. Suzuki, S. Yamano, and F.J. Gonzalez Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27 Cell Metab. 7 2008 302 311 (Pubitemid 351455219)
8. S. Mandard, R. Stienstra, P. Escher, N.S. Tan, I. Kim, F.J. Gonzalez, W. Wahli, B. Desvergne, M. Muller, and S. Kersten Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors Cell. Mol. Life Sci. 64 2007 1145 1157 (Pubitemid 46684553)
9. Y. Zhu, G. Xu, A. Patel, M.M. McLaughlin, C. Silverman, K. Knecht, S. Sweitzer, X. Li, P. McDonnell, R. Mirabile, D. Zimmerman, R. Boyce, L.A. Tierney, E. Hu, G.P. Livi, B. Wolf, S.S. Abdel-Meguid, G.D. Rose, R. Aurora, P. Hensley, M. Briggs, and P.R. Young Cloning, expression, and initial characterization of a novel cytokine-like gene family Genomics 80 2002 144 150 (Pubitemid 36197956)
10. X. Cao, J. Yang, B.R. Burkhardt, Z. Gao, R.K. Wong, S.R. Greene, J. Wu, and B.A. Wolf Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells Am. J. Physiol. Endocrinol. Metab. 289 2005 E543 E550
11. B.R. Burkhardt, M.C. Yang, C.E. Robert, S.R. Greene, K.K. McFadden, J. Yang, J. Wu, Z. Gao, and B.A. Wolf Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter Biochim. Biophys. Acta 1730 2005 215 225 (Pubitemid 41317466)
12. J. Yang, Z. Gao, C.E. Robert, B.R. Burkhardt, H. Gaweska, A. Wagner, J. Wu, S.R. Greene, R.A. Young, and B.A. Wolf Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells Biochemistry 44 2005 11342 11352 (Pubitemid 41209070)
13. J. Yang, C.E. Robert, B.R. Burkhardt, R.A. Young, J. Wu, Z. Gao, and B.A. Wolf Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells Diabetes 54 2005 3217 3228 (Pubitemid 43334378)
14. J. Yang, C. Wang, J. Li, B.R. Burkhardt, C.E. Robert-Cooperman, C. Wilson, Z. Gao, and B.A. Wolf PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells FEBS Lett. 583 2009 3009 3015
15. C. Wang, B.R. Burkhardt, Y. Guan, and J. Yang Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic beta cells and liver Nutr. Rev. 70 2012 100 106
16. C.E. Robert-Cooperman, J.R. Carnegie, C.G. Wilson, J. Yang, J.R. Cook, J. Wu, R.A. Young, B.A. Wolf, and B.R. Burkhardt Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function Diabetes 59 2010 2209 2218
17. B.R. Burkhardt, J.R. Cook, R.A. Young, and B.A. Wolf PDX-1 interaction and regulation of the pancreatic derived factor (PANDER, FAM3B) promoter Biochim. Biophys. Acta 1779 2008 645 651
18. J. Li, Y. Chi, C. Wang, J. Wu, H. Yang, D. Zhang, Y. Zhu, N. Wang, J. Yang, and Y. Guan Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway Hepatology 53 2011 1906 1916
19. C.E. Robert-Cooperman, C.G. Wilson, and B.R. Burkhardt PANDER KO mice on high-fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia FEBS Lett. 585 2011 1345 1349
20. C.G. Wilson, M. Schupp, B.R. Burkhardt, J. Wu, R.A. Young, and B.A. Wolf Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice Endocrinology 151 2010 5174 5184
21. T. Waerner, M. Alacakaptan, I. Tamir, R. Oberauer, A. Gal, T. Brabletz, M. Schreiber, M. Jechlinger, and H. Beug ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells Cancer Cell 10 2006 227 239 (Pubitemid 44311068)
22. M. Gronborg, T.Z. Kristiansen, A. Iwahori, R. Chang, R. Reddy, N. Sato, H. Molina, O.N. Jensen, R.H. Hruban, M.G. Goggins, A. Maitra, and A. Pandey Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell. Proteomics 5 2006 157 171 (Pubitemid 43169348)
23. V.V. Pilipenko, A. Reece, D.I. Choo, and J.H. Greinwald Jr. Genomic organization and expression analysis of the murine Fam3c gene Gene 335 2004 159 168 (Pubitemid 38759762)
24. N.J. de Wit, N. Ijssennagger, E. Oosterink, S. Keshtkar, G.J. Hooiveld, R.P. Mensink, S. Hammer, J.W. Smit, M. Muller, and R.V. der Meer Oit1/Fam3D, a gut-secreted protein displaying nutritional status-dependent regulation J. Nutr. Biochem. 23 2012 1425 1433
25. R. Solmi, P. De Sanctis, C. Zucchini, G. Ugolini, G. Rosati, M. Del Governatore, D. Coppola, T.J. Yeatman, L. Lenzi, A. Caira, S. Zanotti, M. Taffurelli, P. Carinci, L. Valvassori, and P. Strippoli Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR Int. J. Oncol. 25 2004 1049 1056
26. R. Wang, X. Kong, A. Cui, X. Liu, R. Xiang, Y. Yang, Y. Guan, F. Fang, and Y. Chang Sterol-regulatory-element-binding protein 1c mediates the effect of insulin on the expression of Cidea in mouse hepatocytes Biochem. J. 430 2010 245 254
27. X. Qin, X. Xie, Y. Fan, J. Tian, Y. Guan, X. Wang, Y. Zhu, and N. Wang Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice Hepatology 48 2008 432 441
28. Q. Han, X. Zhang, R. Xue, H. Yang, Y. Zhou, X. Kong, P. Zhao, J. Li, J. Yang, Y. Zhu, and Y. Guan AMPK potentiates hypertonicity-induced apoptosis by suppressing NFkappaB/COX-2 in medullary interstitial cells J. Am. Soc. Nephrol. 22 2011 1897 1911
29. H. Zhang, Y. Li, Y. Fan, J. Wu, B. Zhao, Y. Guan, S. Chien, and N. Wang Klotho is a target gene of PPAR-gamma Kidney Int. 74 2008 732 739
30. S. Nakamura, T. Takamura, N. Matsuzawa-Nagata, H. Takayama, H. Misu, H. Noda, S. Nabemoto, S. Kurita, T. Ota, H. Ando, K. Miyamoto, and S. Kaneko Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria J. Biol. Chem. 284 2009 14809 14818
31. Y. Guan Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome J. Am. Soc. Nephrol. 15 2004 2801 2815 (Pubitemid 41103389)
32. J. Yang, L. Chen, X. Zhang, Y. Zhou, D. Zhang, M. Huo, and Y. Guan PPARs and female reproduction: evidence from genetically manipulated mice PPAR Res. 2008 2008 723243
33. X. Ruan, F. Zheng, and Y. Guan PPARs and the kidney in metabolic syndrome Am. J. Physiol. 294 2008 F1032 F1047
34. Y. Higashi, K. Holder, and P. Delafontaine Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway J. Biol. Chem. 285 2010 36361 36368
35. H.J. Welters, A. El Ouaamari, D. Kawamori, J. Meyer, J. Hu, D.M. Smith, and R.N. Kulkarni Rosiglitazone promotes PPARgamma-dependent and -independent alterations in gene expression in mouse islets Endocrinology 153 2012 4593 4599
36. E. Moran-Salvador, M. Lopez-Parra, V. Garcia-Alonso, E. Titos, M. Martinez-Clemente, A. Gonzalez-Periz, C. Lopez-Vicario, Y. Barak, V. Arroyo, and J. Claria Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts FASEB J. 25 2011 2538 2550
37. O. Gavrilova, M. Haluzik, K. Matsusue, J.J. Cutson, L. Johnson, K.R. Dietz, C.J. Nicol, C. Vinson, F.J. Gonzalez, and M.L. Reitman Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J. Biol. Chem. 278 2003 34268 34276 (Pubitemid 37553270)
38. K. Matsusue, M. Haluzik, G. Lambert, S.H. Yim, O. Gavrilova, J.M. Ward, B. Brewer Jr., M.L. Reitman, and F.J. Gonzalez Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes J. Clin. Invest. 111 2003 737 747 (Pubitemid 36278592)
39. V. Ratziu, P. Giral, S. Jacqueminet, F. Charlotte, A. Hartemann-Heurtier, L. Serfaty, P. Podevin, J.M. Lacorte, C. Bernhardt, E. Bruckert, A. Grimaldi, and T. Poynard Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) Trial Gastroenterology 135 2008 100 110 (Pubitemid 351916703)
40. V. Ratziu, F. Charlotte, C. Bernhardt, P. Giral, M. Halbron, G. Lenaour, A. Hartmann-Heurtier, E. Bruckert, and T. Poynard Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial Hepatology 51 2010 445 453
41. G. Musso, R. Gambino, M. Cassader, and G. Pagano A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease Hepatology 52 2010 79 104
42. N. Hay Akt isoforms and glucose homeostasis - the leptin connection Trends Endocrinol. Metab. 22 2011 66 73
43. Z. Cheng, Y. Tseng, and M.F. White Insulin signaling meets mitochondria in metabolism Trends Endocrinol Metab 21 2010 589 598
44. M. Giuliano, O. Pellerito, P. Portanova, G. Calvaruso, A. Santulli, A. De Blasio, R. Vento, and G. Tesoriere Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma Biochimie 91 2009 457 465
45. E. Burgermeister, A. Schnoebelen, A. Flament, J. Benz, M. Stihle, B. Gsell, A. Rufer, A. Ruf, B. Kuhn, H.P. Marki, J. Mizrahi, E. Sebokova, E. Niesor, and M. Meyer A novel partial agonist of peroxisome proliferator- activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro Mol. Endocrinol. 20 2006 809 830
46. M. Collino, M. Aragno, S. Castiglia, G. Miglio, C. Tomasinelli, G. Boccuzzi, C. Thiemermann, and R. Fantozzi Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation Br. J. Pharmacol. 160 2010 1892 1902
47. K. Hino, and H. Nagata Screening for adiponectin secretion regulators Vitam. Horm. 90 2012 125 141
48. X. Sun, R. Han, Z. Wang, and Y. Chen Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone Diabetologia 49 2006 1303 1310
49. A. Da Silva Morais, V. Lebrun, J. Abarca-Quinones, S. Brichard, L. Hue, B. Guigas, B. Viollet, and I.A. Leclercq Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation J. Hepatol. 50 2009 489 500
50. O. Astapova, and T. Leff Adiponectin and PPARgamma: cooperative and interdependent actions of two key regulators of metabolism Vitam. Horm. 90 2012 143 162
51. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277